OBJECTIVE: To predict the 2-year course of activity limitations in patients with early knee and/or hip osteoarthritis (OA). METHODS: The Cohort Hip & Cohort Knee (CHECK) study is a prospective followup study. The CHECK cohort, comprising participants (n = 1,002) with early OA-related knee and/or hip symptoms, was followed for 2 years. Participants completed questionnaires and underwent physical, laboratory, and radiographic examination. Regression models were used to examine whether baseline variables predicted the course of activity limitations as measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Analyses were performed separately for participants with knee symptoms and participants with hip symptoms. RESULTS: After 2 years of followup, activity limitations slightly decreased. Large between-subject variation was observed in WOMAC change scores. In participants with knee symptoms, young age, non-Western ethnicity, bilateral hip pain, morning stiffness in the knee, high comorbidity count, high body mass index, high bodily pain, poor general health perception, and pain coping strategy were associated with a poor 2-year outcome on activity limitations. In participants with hip symptoms, few activity limitations at baseline, bilateral hip pain, morning stiffness in the knee, high comorbidity count, low active hip flexion, poor general health perception, and pain coping strategy were associated with a poor 2-year outcome on activity limitations. CONCLUSION: After 2 years of followup, large between-subject variation was observed in the course of activity limitations. The course of activity limitations is to some extent already predictable at an early stage of knee and hip OA.
OBJECTIVE: To predict the 2-year course of activity limitations in patients with early knee and/or hip osteoarthritis (OA). METHODS: The Cohort Hip & Cohort Knee (CHECK) study is a prospective followup study. The CHECK cohort, comprising participants (n = 1,002) with early OA-related knee and/or hip symptoms, was followed for 2 years. Participants completed questionnaires and underwent physical, laboratory, and radiographic examination. Regression models were used to examine whether baseline variables predicted the course of activity limitations as measured with the Western Ontario and McMaster Universities Osteoarthritis Index (WOMAC). Analyses were performed separately for participants with knee symptoms and participants with hip symptoms. RESULTS: After 2 years of followup, activity limitations slightly decreased. Large between-subject variation was observed in WOMAC change scores. In participants with knee symptoms, young age, non-Western ethnicity, bilateral hip pain, morning stiffness in the knee, high comorbidity count, high body mass index, high bodily pain, poor general health perception, and pain coping strategy were associated with a poor 2-year outcome on activity limitations. In participants with hip symptoms, few activity limitations at baseline, bilateral hip pain, morning stiffness in the knee, high comorbidity count, low active hip flexion, poor general health perception, and pain coping strategy were associated with a poor 2-year outcome on activity limitations. CONCLUSION: After 2 years of followup, large between-subject variation was observed in the course of activity limitations. The course of activity limitations is to some extent already predictable at an early stage of knee and hip OA.
Authors: Jasmijn F M Holla; Diana C Sanchez-Ramirez; Marike van der Leeden; Johannes C F Ket; Leo D Roorda; Willem F Lems; Martijn P M Steultjens; Joost Dekker Journal: J Behav Med Date: 2014-05-20
Authors: Chang Xu; Nathalie E Marchand; Jeffrey B Driban; Timothy McAlindon; Charles B Eaton; Bing Lu Journal: Am J Clin Nutr Date: 2020-03-01 Impact factor: 7.045
Authors: A H Chang; J S Chmiel; O Almagor; K W Hayes; A Guermazi; P V Prasad; K C Moisio; Y Zhang; J Szymaszek; L Sharma Journal: Osteoarthritis Cartilage Date: 2019-02-28 Impact factor: 6.576
Authors: Alberto Migliore; Carlo Alberto Scirè; Loreto Carmona; Gabriel Herrero-Beaumont; Emanuele Bizzi; Jaime Branco; Greta Carrara; Xavier Chevalier; Ledio Collaku; Spiros Aslanidis; Lev Denisov; Luigi Di Matteo; Gerolamo Bianchi; Demirhan Diracoglu; Bruno Frediani; Emmanuel Maheu; Natalia Martusevich; Gian Filippo Bagnato; Magda Scarpellini; Giovanni Minisola; Nurullah Akkoc; Roberta Ramonda; Tatiana Barskova; Durda Babic-Naglic; Jose Vicente Moreno Muelas; Ruxandra Ionescu; Rasho Rashkov; Nemanja Damjanov; Marco Matucci Cerinic Journal: Rheumatol Int Date: 2017-04-27 Impact factor: 2.631
Authors: Britt Elin Øiestad; Daniel K White; Ross Booton; Jingbo Niu; Yuqing Zhang; Jim Torner; Cora E Lewis; Michael Nevitt; Michael LaValley; David T Felson Journal: Arthritis Care Res (Hoboken) Date: 2016-03 Impact factor: 4.794